2024-01-10Zeitschriftenartikel
Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study
Maurel, Marine; Pozo, Francisco; Pérez-Gimeno, Gloria; Buda, Silke; Sève, Noémie; Oroszi, Breatrix; Hooiveld, Mariette; Gomez, Verónica; Domegan, Lisa; Martínez-Baz, Iván; Ilíc, Maja; Carnahan, Anna Sara; Mihai, Maria Elena; Martínez, Ana; Goerlitz, Luise; Enouf, Vincent; Horváth, Judit Krisztina; Dijkstra, Frederika; Rodrigues, Ana Paula; Bennett, Charlene; Trobajo-Sanmartín, Camino; Mlinarić, Ivan; Latorre-Margalef, Neus; Ivanciuc, Alina; Lopez, Aurora; Dürrwald, Ralf; Falchi, Alessandra; Túri, Gergő; Meijer, Adam; Melo, Aryse; O'Donnell, Joan; Castilla, Jesús; Višekruna Vučina, Vesna; Samuelsson Hagey, Tove; Lazar, Mihaela; Kaczmarek, Marlena; Bacci, Sabrina; Kissling, Esther; VEBIS study team
Background:
Influenza A(H3N2) viruses dominated early in the 2022–2023 influenza season in Europe, followed by higher circulation of influenza A(H1N1)pdm09 and B viruses. The VEBIS primary care network estimated the ...
